BioPharma Dive December 16, 2024

Sponsored content By PHC Corporation of North America

Cell & gene therapy stands at the forefront of modern medicine, promising transformative treatments for previously intractable diseases. But, as the field continues to advance, a growing body of evidence suggests that we may need to fundamentally rethink one of the most basic aspects of cell culture: O2 concentration.

While the field has made remarkable strides in optimizing numerous culture parameters, the continued use of non-physiological O2 levels could be stifling our efforts to conduct more insightful research and develop better, more effective therapies.

Normoxia — the norm for cells?

Conventionally, mammalian cells have been cultured at atmospheric or ‘normoxic’ O2 levels — that is, at O2 levels ranging from 20–21%....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article